Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Emory University Juvenile Diabetes Research Foundation |
---|---|
Information provided by: | Emory University |
ClinicalTrials.gov Identifier: | NCT00133809 |
This trial will study the ability of islet transplantation to restore glycemic control and achieve insulin independence in type 1 diabetic subjects with life-threatening hypoglycemia and unawareness, or recurrent hyperglycemia with ketoacidosis.
Condition | Intervention | Phase |
---|---|---|
Diabetes Mellitus, Type 1 |
Procedure: Human Islet Transplantation |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | Islet Transplantation in Type 1 Diabetes Using the Edmonton Protocol of Steroid Free Immunosuppression |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Georgia | |
The Emory Transplant Center | |
Atlanta, Georgia, United States, 30322 |
Principal Investigator: | Christian P Larsen, MD PhD | Emory University |
Principal Investigator: | Thomas Pearson, MD PhD | Emory University |
Study ID Numbers: | 10402 |
Study First Received: | August 22, 2005 |
Last Updated: | October 25, 2005 |
ClinicalTrials.gov Identifier: | NCT00133809 |
Health Authority: | United States: Food and Drug Administration |
Type 1 Diabetes Islet Transplantation Immunology |
Autoimmune Diseases Metabolic Diseases Diabetes Mellitus, Type 1 Diabetes Mellitus |
Endocrine System Diseases Endocrinopathy Metabolic disorder Glucose Metabolism Disorders |
Immune System Diseases |